GIVN’s approved product in the US is for the small intestine, which is why you haven’t heard much about it. If the PillCam product for the colon gets FDA approval, it will be a big news item.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.